Quince Therapeutics Inc
Follow $QNCX
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $QNCX by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is QNCX moving today?
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
QNCX overview
Related filings and maps
Congress activity in QNCX
No receipt-qualified Congressional disclosure is present for QNCX in the cached public ledger.
QNCX contract awards, year to date.
Public federal awards linked to this ticker.
QNCX lobbying filings, year to date.
Registered lobbying filings matched to Quince Therapeutics Inc.